Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Adderall Shortages Spread to 4 Pharmaceutical Companies Including Teva, Novartis - Bloomberg
Teva stock drops after conspiracy allegations on hiking drug prices
Teva Is at Center of Drug Price-Fixing Case Filed by States - Bloomberg
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva Generic Price-Fixing Securities Suit Gets Class Status (1)
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva makes $40.1 billion takeover bid for Mylan | Mint
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Israeli pharmaceutical company donating millions of doses of potential coronavirus drug to the U.S.
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
